(Q46713051)

24 December 2017

title

Role of aldosterone in diabetic nephropathy (English)

1 reference

24 December 2017

author name string

Dae Ryong Cha

1

1 reference

24 December 2017

Young Sun Kang

2

1 reference

24 December 2017

Sang Youb Han

3

1 reference

24 December 2017

Yi Hwa Jee

4

1 reference

24 December 2017

Kum Hyun Han

5

1 reference

24 December 2017

Hyoung Kyu Kim

6

1 reference

24 December 2017

Jee Young Han

7

1 reference

24 December 2017

Young Sik Kim

8

1 reference

24 December 2017

publication date

1 October 2005

1 reference

24 December 2017

published in

Nephrology

1 reference

24 December 2017

volume

10 Suppl

1 reference

24 December 2017

page(s)

S37-9

1 reference

24 December 2017

Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in the Adult US Population : Data From the Health Examination Surveys, 1960 to 1991

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Disorders of aldosterone biosynthesis and action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Spironolactone and angiotensin receptor blocker in nondiabetic renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Effectiveness of aldosterone blockade in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Aldosterone induces a vascular inflammatory phenotype in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Aldosterone-induced inflammation in the rat heart : role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Progression of tubulointerstitial injury by osteopontin-induced macrophage recruitment in advanced diabetic nephropathy of transgenic (mRen-2)27 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

50th anniversary of aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Antiproteinuric effects of mineralocorticoid receptor blockade in patients with chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

Role of connective tissue growth factor in renal tubular epithelial-myofibroblast transdifferentiation and extracellular matrix accumulation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00455.X

10.1111/J.1440-1797.2005.00455.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017